<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04871022</url>
  </required_header>
  <id_info>
    <org_study_id>UTuniselmanar3</org_study_id>
    <nct_id>NCT04871022</nct_id>
  </id_info>
  <brief_title>Double-layer Versus Purse Uterine Closure Techniques : Impact on Residual Myometrial Thickness After Cesarean</brief_title>
  <official_title>Double-layer Versus Purse Uterine Closure Techniques : Impact on Residual Myometrial Thickness After Cesarean</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Tunis El Manar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Tunis El Manar</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are different surgical techniques of uterine closure during cesarean. Currently data&#xD;
      suggest that the double layer unlocked closure technique is associated with better uterine&#xD;
      scar healing, and this technique is considered the gold standard.&#xD;
&#xD;
      This study compares two techniques of uterine closure on myometrium thickness:&#xD;
&#xD;
        1. Double layer unlocked suture;&#xD;
&#xD;
        2. Purse suture of the uterus with a first continuous purse suture of the deep portion of&#xD;
           the myometrium and a second unlocked continuous suture including the remaining part of&#xD;
           the myometrium.&#xD;
&#xD;
      The primary outcome is the mean residual myometrium thickness at the site of the uterine scar&#xD;
      evaluated by transvaginal ultrasound at six months after cesarean.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Residual myometrium thickness</measure>
    <time_frame>6 months after intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>Same day of intervention: day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimated blood loss</measure>
    <time_frame>Same day of intervention: day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean number of haemostatic sutures</measure>
    <time_frame>Same day of intervention: day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>scar width</measure>
    <time_frame>Same day of intervention: day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Uterine Scar Defect</condition>
  <arm_group>
    <arm_group_label>Double layer unlocked uterine closer</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Double layer closure with a first continuous unlocked suture of the deep portion of the myometrium and a second unlocked continuous suture that approximate the upper portion of the myometrium.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Purse uterine closer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Purse suture of the uterus with a first continuous purse suture of the deep portion of the myometrium and a second unlocked continuous suture including the remaining part of the myometrium</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Double layer closure of the hysterotomy</intervention_name>
    <description>Double layer closure with a first continuous unlocked suture of the deep portion of the myometrium and a second unlocked continuous suture that approximate the upper portion of the myometrium.</description>
    <arm_group_label>Double layer unlocked uterine closer</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Purse closure of the hysterotomy</intervention_name>
    <description>Purse suture of the uterus with a first continuous purse suture of the deep portion of the myometrium and a second unlocked continuous suture including the remaining part of the myometrium</description>
    <arm_group_label>Purse uterine closer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Planned cesarean&#xD;
&#xD;
          -  Primary cesarean&#xD;
&#xD;
          -  â‰¥ 38 gestational weeks&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previous cesarean&#xD;
&#xD;
          -  Women &lt; 18 years old&#xD;
&#xD;
          -  Multiple gestation&#xD;
&#xD;
          -  Mullerian anomalies&#xD;
&#xD;
          -  Active labor&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  BMI &gt;35 kg/m2&#xD;
&#xD;
          -  Placenta praevia&#xD;
&#xD;
          -  Chronic systemic disease&#xD;
&#xD;
          -  Covid-19 infection&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>48 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmed Halouani, MD</last_name>
    <phone>50527325</phone>
    <phone_ext>216</phone_ext>
    <email>ahmed.halouani@fmt.utm.tn</email>
  </overall_contact>
  <location>
    <facility>
      <name>University hospital Mongi Slim la Marsa</name>
      <address>
        <city>Tunis</city>
        <state>La Marsa</state>
        <zip>2046</zip>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lamia Khalfa</last_name>
      <phone>70109181</phone>
      <phone_ext>216</phone_ext>
      <email>lamiaziko13@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>April 28, 2021</study_first_submitted>
  <study_first_submitted_qc>April 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Tunis El Manar</investigator_affiliation>
    <investigator_full_name>Ahmed Halouani</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>niche</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

